ASP Isotopes plans JSE listing to enhance local investment opportunities

ASP Isotopes, which uses its own South Africa developed technology to enrich isotopes, plans to add to its 2022 Nasdaq listing with a listing on the Main Board of the Johannesburg Stock Exchange.

- EDWARD WEST

The company, owned by its CEO Paul Mann and US-based institutional global investment funds, develops technologies and processes for the enrichment of isotopes that can be used in the medical, semiconductor and nuclear industries, born out of years of research and development, originally developed in South Africa.

ASPI is a US incorporated company that has been listed on the Nasdaq since 2022. It has a market capitalisation in the US of $400 million, or R7.5 billion, and it plans to list on the JSE later this year, subject to regulatory approvals.

"While our investor base has been created in the US and Europe, the beating heart of our company is in South Africa, with 97% of our employees and all our operating assets being located in South Africa," said ASPI chairman and CEO Paul Mann, who is also CEO of Quantum Leap Energy.

He said in an interview with BR the intention was not necessarily to raise capital with the JSE listing, but to also give South African investors an opportunity to invest in the company that was, at its heart, South African.

"We have to thank our South African staff, service providers and regulators for helping us achieve all we have done over the last four years, and we owe it to South Africa to make our securities available to the local community," he said.